| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |